Gyeonggi-do, South Korea

Man-Seok Ju

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Man-Seok Ju

Introduction

Man-Seok Ju is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents. His work focuses on addressing critical health issues such as hypertension and cancer.

Latest Patents

Man-Seok Ju holds a patent for an "Endothelin receptor type A activity regulating antibody." This invention relates to a monoclonal antibody or a fragment that specifically recognizes and binds to the extracellular domain of the endothelin receptor type A. The monoclonal antibody is designed for use as a therapeutic agent for conditions associated with endothelin receptor type A, including hypertension and cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Man-Seok Ju has been associated with Hedgehog, Inc., where he has contributed to various innovative projects. His expertise in monoclonal antibodies has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Man-Seok Ju has worked alongside talented colleagues such as Sang Taek Jung and Yeon Gyu Yu. Their collaborative efforts have further advanced the research and development of innovative solutions in their field.

Conclusion

Man-Seok Ju's contributions to the field of biomedical research highlight his commitment to innovation and improving health outcomes. His work on the endothelin receptor type A activity regulating antibody exemplifies the potential of targeted therapies in treating serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…